Kelly Brazzo is Co-Founder and CEO of the CureLGMD2i Foundation and a passionate advocate inspired by her daughter, Sammy, who is living with Limb-Girdle Muscular Dystrophy (LGMD) 2I/R9 - an ultra-rare and progressive muscle-wasting condition with significant unmet need.

Combining personal experience with 24 years in the healthcare and special education settings, Kelly brings an authentic and compelling voice to discussions on rare disease advocacy, patient-centered care, and the urgency of advancing research and patient focused therapeutic development. She leads CureLGMD2i’s mission to raise awareness, strengthen advocacy efforts, and accelerate progress toward a cure.

Prior to her work in the nonprofit sector, Kelly served at Lancaster-Lebanon IU 13 as a speech-language pathologist and feeding team consultant and was Director of Rehabilitation at EnduraCare, where she led multidisciplinary care teams to improve the quality of life for individuals and families navigating complex medical needs

Kelly holds a Master of Science in Speech-Language Pathology from Columbia University and a Bachelor of Science from Old Dominion University.